Skip to main content
. 2020 May 17;10(15):6695–6714. doi: 10.7150/thno.45164

Figure 7.

Figure 7

Antitumor efficacy of different formulations and relative body weight percentage on SAS/luc-bearing mice. (A) Antitumor efficacy of SAS/luc-bearing mice intravenously injected with different formulations. Tumor growth was measured with digital calipers every 2 days (*statistical significance at P < 0.05; **P < 0.01; ***P < 0.001). (B) IVIS images of SAS/luc-bearing mice treated with different formulations. (C) TUNEL analysis of in vivo apoptosis in SAS tumor cells (green) on the day after the last administration. Nuclei (blue) were stained with Hoechst. Scale bar, 100 μm. (D) Body weight of SAS/luc-bearing mice treated with different formulations for 20 days.